R.BIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jul 2024)
What this means for you
This application is over — abandoned 15 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97419503
- Mark type
- Word mark
- Filed
- 19 May 2022
- Published for opposition
- 17 Oct 2023
- Abandoned
- 15 Jul 2024
- Attorney of record
- Nina Habib Borders
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes in the field of Virology and Immunology; Medical diagnostic testing, monitoring, and reporting services in the field of virology, immunology, pathology and molecular biology; medical diagnostic services in the field of molecular diagnostics; Medical diagnostic testing, monitoring, and reporting services in the field of virology, immunology, pathology, and molecular biology, namely, Customizable medical testing programs for workplaces, schools, events, concerts, festivals, and other groups; Virus testing for medical diagnostic or treatment purposes
Owner
- RenegadeXBio, PBC, San Francisco, CA, US
- RenegadeXBio, PBC, San Francisco, CA, US
Prosecution history
- 15 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 May 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 16 May 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 10 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Mar 2023 — NON-FINAL ACTION E-MAILED
- 10 Mar 2023 — NON-FINAL ACTION WRITTEN